{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:59:30Z","timestamp":1777532370272,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12944-018-0763-z","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T16:55:56Z","timestamp":1525280156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia \u2013 a preliminary report"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9214-7808","authenticated-orcid":false,"given":"C. S.","family":"Paththinige","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R. D. K.","family":"Rajapakse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. R.","family":"Constantine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. P.","family":"Sem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. R.","family":"Singaraja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. W.","family":"Jayasekara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. H. W.","family":"Dissanayake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"key":"763_CR1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/ncpcardio0836","volume":"4","author":"AK Soutar","year":"2007","unstructured":"Soutar AK, Naoumova RP. Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med. 2007;4:214\u201325.","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"763_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0004.2007.00915.x","volume":"73","author":"M Varret","year":"2008","unstructured":"Varret M, Abifadel M, Rab\u00e8s JP, Boileau C. Genetic heterogeneity of autosomal dominant hypercholesterolemia. Clin Genet. 2008;73:1\u20133.","journal-title":"Clin Genet"},{"key":"763_CR3","unstructured":"Youngblom E, Pariani M, Knowles JW. Familial Hypercholesterolemia. 2014 Jan 2 [Updated 2016 Dec 8]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132017. \n                    https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK174884\/\n                    \n                  . Accessed 10 Aug 2017."},{"key":"763_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/humu.1380010602","volume":"1","author":"HH Hobbs","year":"1992","unstructured":"Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat. 1992;1:445\u201366.","journal-title":"Hum Mutat"},{"key":"763_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/aje\/kwh236","volume":"160","author":"MA Austin","year":"2004","unstructured":"Austin MA, Hutter CM, Zimmern RL, Humphries SE. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol. 2004;160:407\u201320.","journal-title":"Am J Epidemiol"},{"key":"763_CR6","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/01.ATV.20.9.e41","volume":"20","author":"S Bertolini","year":"2000","unstructured":"Bertolini S, Cantafora A, Averna M, Cortese C, Motti C, Martini S, et al. Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype. Arterioscler Thromb Vasc Biol. 2000;20:e41\u201352.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"763_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.atherosclerosis.2013.01.007","volume":"227","author":"S Bertolini","year":"2013","unstructured":"Bertolini S, Pisciotta L, Rabacchi C, Cefal\u00f9 AB, Noto D, Fasano T, et al. Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy. Atherosclerosis. 2013;227:342\u20138.","journal-title":"Atherosclerosis"},{"key":"763_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.atherosclerosis.2013.12.028","volume":"233","author":"PC Santos","year":"2014","unstructured":"Santos PC, Morgan AC, Jannes CE, Turolla L, Krieger JE, Santos RD, et al. Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia. Atherosclerosis. 2014;233:206\u201310.","journal-title":"Atherosclerosis"},{"key":"763_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/01213011-200504000-00005","volume":"15","author":"G Miltiadous","year":"2005","unstructured":"Miltiadous G, Xenophontos S, Bairaktari E, Ganotakis M, Cariolou M, Elisaf M. Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia. Pharmacogenet Genomics. 2005;15:219\u201325.","journal-title":"Pharmacogenet Genomics"},{"issue":"20","key":"763_CR10","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1161\/CIRCULATIONAHA.105.565507","volume":"112","author":"KC Koeijvoets","year":"2005","unstructured":"Koeijvoets KC, Rodenburg J, Hutten BA, Wiegman A, Kastelein JJ, Sijbrands EJ. Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia. Circulation. 2005;112(20):3168\u201373.","journal-title":"Circulation"},{"key":"763_CR11","unstructured":"ClinVar (TM). National Center for Biotechnology Information, National Library of Medicine, Bethesda. Available from \n                    http:\/\/www.ncbi.nlm.nih.gov\/clinvar\/\n                    \n                  . Accessed 12 Aug 2017."},{"issue":"5","key":"763_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1469-1809.2012.00724.x","volume":"76","author":"E Usifo","year":"2012","unstructured":"Usifo E, Leigh SE, Whittall RA, Lench N, Taylor A, Yeats C, et al. Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment. Ann Hum Genet. 2012;76(5):387\u2013401.","journal-title":"Ann Hum Genet"},{"key":"763_CR13","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"BG Nordestgaard","year":"2013","unstructured":"Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European atherosclerosis society. Eur Heart J. 2013;34:3478\u201390.","journal-title":"Eur Heart J"},{"key":"763_CR14","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3109\/07853890108995954","volume":"33","author":"AF Vuorio","year":"2001","unstructured":"Vuorio AF, Aalto-Set\u00e4l\u00e4 K, Koivisto UM, Turtola H, Nissen H, Kovanen PT, et al. Familial hypercholesterolaemia in Finland: common, rare and mild mutations of the LDL receptor and their clinical consequences. Ann Med. 2001;33:410\u201321.","journal-title":"Ann Med"},{"key":"763_CR15","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s00439-001-0628-8","volume":"109","author":"SW Fouchier","year":"2001","unstructured":"Fouchier SW, Defesche JC, Umans-Eckenhausen MA, Kastelein JJ. The molecular basis of familial hypercholesterolemia in the Netherlands. Hum Genet. 2001;109:602\u201315.","journal-title":"Hum Genet"},{"key":"763_CR16","doi-asserted-by":"publisher","first-page":"E682","DOI":"10.1002\/humu.21002","volume":"30","author":"M Abifadel","year":"2009","unstructured":"Abifadel M, Rab\u00e8s JP, Jambart S, Halaby G, Gannag\u00e9-Yared MH, Sarkis A, et al. The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene. Hum Mutat. 2009;30:E682\u201391.","journal-title":"Hum Mutat"},{"key":"763_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/(SICI)1098-1004(1997)10:1<36::AID-HUMU5>3.0.CO;2-K","volume":"10","author":"V Gudnason","year":"1997","unstructured":"Gudnason V, Sigurdsson G, Nissen H, Humphries SE. Common founder mutation in the LDL receptor gene causing familial hypercholesterolaemia in the Icelandic population. Hum Mutat. 1997;10:36.","journal-title":"Hum Mutat"},{"key":"763_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/humu.20105","volume":"24","author":"GV Dedoussis","year":"2004","unstructured":"Dedoussis GV, Schmidt H, Genschel J. LDL-receptor mutations in Europe. Hum Mutat. 2004;24:443\u201359.","journal-title":"Hum Mutat"},{"key":"763_CR19","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/hrt.2008.162909","volume":"95","author":"R Minhas","year":"2009","unstructured":"Minhas R, Humphries SE, Qureshi N, Neil HA. Controversies in familial hypercholesterolaemia: recommendations of the NICE guideline development group for the identification and management of familial hypercholesterolaemia. Heart. 2009;95:584\u20137.","journal-title":"Heart"},{"issue":"1","key":"763_CR20","first-page":"18","volume":"150","author":"EP Walma","year":"2006","unstructured":"Walma EP, Visseren FL, Jukema JW, Kastelein JJ, Hoes AW, Stalenhoef AF. The practice guideline \u2018diagnosis and treatment of familial hypercholesterolaemia\u2019 of the Dutch health care insurance board. Ned Tijdschr Geneeskd. 2006;150(1):18\u201323.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"763_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2003.11.010","volume":"173","author":"F Civeira","year":"2004","unstructured":"Civeira F, International Panel on Management of Familial Hypercholesterolemia. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis. 2004;173:55\u201368.","journal-title":"Atherosclerosis"},{"key":"763_CR22","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1161\/01.ATV.0000177811.14176.2b","volume":"25","author":"F Civeira","year":"2005","unstructured":"Civeira F, Castillo S, Alonso R, Merino-Ibarra E, Cenarro A, Artied M, et al. Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutation. Arterioscler Thromb Vasc Biol. 2005;25:1960\u20135.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"763_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1055\/s-2004-822989","volume":"l","author":"TP Leren","year":"2004","unstructured":"Leren TP, Manshaus T, Skovholt U, Skodje T, Nossen IE, Teie C, et al. Application of molecular genetics for diagnosing familial hypercholesterolemia in Norway: results from a family-based screening program. Semin Vasc Med. 2004;l:75\u201385.","journal-title":"Semin Vasc Med"},{"key":"763_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00109-005-0019-z","volume":"84","author":"SE Humphries","year":"2006","unstructured":"Humphries SE, Cranston T, Allen M, Middleton-Price H, Fernandez MC, Senior V, et al. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing. J Mol Med. 2006;84:203\u201314.","journal-title":"J Mol Med"},{"key":"763_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s004390050263","volume":"98","author":"A Reshef","year":"1996","unstructured":"Reshef A, Nissen H, Triger L, Hensen TS, Eliav O, Schurr D, et al. Molecular genetics of familial hypercholesterolemia in Israel. Hum Genet. 1996;98:581\u20136.","journal-title":"Hum Genet"},{"key":"763_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5551\/jat.RV16008","volume":"24","author":"H Mabuchi","year":"2017","unstructured":"Mabuchi H. Half a century Tales of familial hypercholesterolemia (FH) in Japan. J Atheroscler Thromb. 2017;24:189\u2013207.","journal-title":"J Atheroscler Thromb"},{"key":"763_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1399-0004.1993.tb03821.x","volume":"43","author":"MJ Kotze","year":"1993","unstructured":"Kotze MJ, Davis HJ, Bissbort S, Langenhoven E, Brusnicky J, Oosthuizen CJ. Intrafamilial variability in the clinical expression of familial hypercholesterolemia: importance of risk factor determination for genetic counselling. Clin Genet. 1993;43:295\u20139.","journal-title":"Clin Genet"},{"key":"763_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1006\/bmme.1996.2549","volume":"60","author":"E Levy","year":"1997","unstructured":"Levy E, Minnich A, Cacan SL, Thibault L, Giroux LM, Davignon J, et al. Association of an exon 3 mutation (Trp66\u2192 Gly) of the LDL receptor with variable expression of familial hypercholesterolemia in a French Canadian family. Biochem Mol Med. 1997;60:59\u201369.","journal-title":"Biochem Mol Med"},{"key":"763_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1399-0004.1995.tb03925.x","volume":"47","author":"M Roy","year":"1995","unstructured":"Roy M, Sing CF, Betard C, Davignon J. Impact of a common mutation of the LDL receptor gene, in French-Canadian patients with familial hypercholesterolemia, on means, variances and correlations among traits of lipid metabolism. Clin Genet. 1995;47:59\u201367.","journal-title":"Clin Genet"},{"key":"763_CR30","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1161\/01.ATV.17.11.3092","volume":"17","author":"XM Sun","year":"1997","unstructured":"Sun XM, Patel DD, Knight BL, Soutar AK. Comparison of the genetic defect with LDL-receptor activity in cultured cells from patients with a clinical diagnosis of heterozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1997;17:3092\u2013101.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"763_CR31","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1186\/s40064-016-3763-3","volume":"5","author":"R Du","year":"2016","unstructured":"Du R, Fan LL, Lin MJ, He ZJ, Huang H, Chen YQ, et al. Mutation detection in Chinese patients with familial hypercholesterolemia. Spring. 2016;5:2095.","journal-title":"Spring"},{"key":"763_CR32","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.atherosclerosis.2012.07.030","volume":"224","author":"AJ Hooper","year":"2012","unstructured":"Hooper AJ, Nguyen LT, Burnett JR, Bates TR, Bell DA, Redgrave TG, et al. Genetic analysis of familial hypercholesterolaemia in Western Australia. Atherosclerosis. 2012;224:430\u20134.","journal-title":"Atherosclerosis"},{"key":"763_CR33","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2012.02.019","volume":"223","author":"FJ Raal","year":"2012","unstructured":"Raal FJ, Santos RD. Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment. Atherosclerosis. 2012;223:262\u20138.","journal-title":"Atherosclerosis"},{"key":"763_CR34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11:361\u20132.","journal-title":"Nat Methods"},{"key":"763_CR35","doi-asserted-by":"crossref","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen\u20102. Curr Protoc Hum Genet. 2013;76:7.20.1-7.20.41.","DOI":"10.1002\/0471142905.hg0720s76"},{"key":"763_CR36","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/bioinformatics\/btv195","volume":"31","author":"Y Choi","year":"2015","unstructured":"Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31:2745\u20137.","journal-title":"Bioinformatics"},{"issue":"7","key":"763_CR37","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073\u201381.","journal-title":"Nat Protoc"},{"key":"763_CR38","doi-asserted-by":"publisher","first-page":"RRN1238","DOI":"10.1371\/currents.RRN1238","volume":"3","author":"RM Ned","year":"2011","unstructured":"Ned RM, Sijbrands E. Cascade screening for familial hypercholesterolemia (FH). Plos Curr. 2011;3:RRN1238. \n                    https:\/\/doi.org\/10.1371\/currents.RRN1238\n                    \n                  .","journal-title":"Plos Curr"},{"key":"763_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(00)03587-X","volume":"357","author":"MA Umans-Eckenhausen","year":"2001","unstructured":"Umans-Eckenhausen MA, Defesche JC, Sijbrands EJ, Scheerder RL, Kastelein JJ. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet. 2001;357:165\u20138.","journal-title":"Lancet"},{"key":"763_CR40","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1399-0004.2004.00320.x","volume":"66","author":"TP Leren","year":"2004","unstructured":"Leren TP. Cascade genetic screening for familial hypercholesterolemia. Clin Genet. 2004;66:483\u20137.","journal-title":"Clin Genet"},{"key":"763_CR41","doi-asserted-by":"publisher","first-page":"e9220","DOI":"10.1371\/journal.pone.0009220","volume":"5","author":"R Huijgen","year":"2010","unstructured":"Huijgen R, Kindt I, Verhoeven SB, Sijbrands EJ, Vissers MN, Kastelein JJ, et al. Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal. PLoS One. 2010;5:e9220.","journal-title":"PLoS One"},{"key":"763_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000111637","volume":"11","author":"TP Leren","year":"2008","unstructured":"Leren TP, Finborud TH, Manshaus TE, Ose L, Berge KE. Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening. Public Health Genomics. 2008;11:26\u201335.","journal-title":"Public Health Genomics"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0763-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-018-0763-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0763-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T19:14:14Z","timestamp":1556738054000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-018-0763-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["763"],"URL":"https:\/\/doi.org\/10.1186\/s12944-018-0763-z","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,2]]},"assertion":[{"value":"9 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol and the form of consent were approved by the Ethics Review Committee, Faculty of Medicine, University of Colombo, Sri Lanka. Written informed consent for the participation in this study and for the genetic testing was obtained from all the participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the participants provided written informed consent for the publication of the results of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"100"}}